We are live on ! Find out more
BOLD

Boundless Bio

54 hedge funds and large institutions have $419M invested in Boundless Bio in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,015% more capital invested

Capital invested by funds: $37.6M → $419M (+$381M)

17.98% more ownership

Funds ownership: 58.13%76.11% (+18%)

2% less funds holding

Funds holding: 5554 (-1)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

13% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 15

Holders
54
Holders Change
-1
Holders Change %
-1.82%
% of All Funds
0.72%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
13
Reduced
15
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
51
Sterling Capital Management
North Carolina
$180 +$222 +107 +892%
TWD
52
True Wealth Design
Ohio
$8 +$10 +5 New
EWA
53
EverSource Wealth Advisors
Alabama
$5 +$6 +3 New
UOC
54
UBS O'Connor
Illinois
-$406K -140,000 Closed
BCM
55
Bridgeway Capital Management
Texas
-$145K -50,000 Closed
Squarepoint
56
Squarepoint
New York
-$93.3K -32,182 Closed
Two Sigma Investments
57
Two Sigma Investments
New York
-$40K -13,808 Closed
Verition Fund Management
58
Verition Fund Management
Connecticut
-$33.8K -11,665 Closed
SG Americas Securities
59
SG Americas Securities
New York
-$31K -10,753 Closed
AWM
60
Avior Wealth Management
Nebraska
-$353 -122 Closed
Deutsche Bank
61
Deutsche Bank
Germany
-$281 -97 Closed

BOLD Hedge Fund Activity: Q1 2025 in Review

54 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Boundless Bio (BOLD) for Q1 2025, worth a combined $419M — up 1,015% from $37.6M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of BOLD and 7 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 13 added.

The largest buyer was Nuveen, adding an estimated $8.16M. The largest seller was UBS O'Connor, exiting entirely with an estimated $406K sold.

  • 54 institutional investors held Boundless Bio (BOLD) as of Q1 2025, down from 55 in Q4 2024.
  • Funds reported $419M of Boundless Bio stock for Q1 2025, up 1,015% quarter-over-quarter.
  • 7 funds opened new Boundless Bio positions in Q1 2025 and 8 closed out, a net change of -1 holder.
  • The largest Boundless Bio buyer in Q1 2025 was Nuveen, an estimated $8.16M added.
  • The largest Boundless Bio seller in Q1 2025 was UBS O'Connor, an estimated $406K sold.

Based on aggregated 13F filings for Q1 2025.